The amount of LAG-3+PD-1+ T cells is different in various molecular subtypes of breast cancer, Du et al. showed that the highest expression was observed in TNBC and the lowest in ER+/PR+ breast cancer [108]. This evidence concerns the gene LAG3 and breast carcinoma.